DMII Drugs Made In America Acquisition II Corp.: institutional ownership and insider trading
70 funds reported holding $458M of Drugs Made In America Acquisition II Corp. in their latest 13F filings; in Q2 2026 funds net bought $15.6M, with 6 new positions and 4 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding DMII
- Izzy Englander (Millennium Management): $20.1M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $14.8M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $8.92M, 0.0% of the portfolio
Largest institutional holders of DMII
- Karpus Management, Inc. — $28.0M
- MMCAP International Inc. SPC — $27.2M
- Magnetar Financial LLC — $27.2M
- GLAZER CAPITAL, LLC — $23.6M
- HIGHBRIDGE CAPITAL MANAGEMENT LLC — $22.6M
- MILLENNIUM MANAGEMENT LLC — $20.1M
- Hudson Bay Capital Management LP — $19.8M
- WOLVERINE ASSET MANAGEMENT LLC — $18.7M
- Polar Asset Management Partners Inc. — $15.1M
- TENOR CAPITAL MANAGEMENT Co., L.P. — $15.1M
Recent DMII insider trades
- Sep 26, 2025: Stockwell Lynn sold 7,966,667 shares ($0)
- Sep 26, 2025: Stockwell Lynn bought 700,000 shares ($0)
- Sep 26, 2025: Drugs Made In America Acquisition II LLC sold 7,966,667 shares ($0)
- Sep 26, 2025: Drugs Made In America Acquisition II LLC bought 700,000 shares ($0)
5%+ owners
- Drugs Made In America Acquisition II LLC: 10.2% (Schedule 13D, filed Oct 2, 2025)